000			06160nam a22005295i 4500
003			DE-He213
005			20191014043223.0
007			cr nn 008mamaa
008			100301s2006 it | s |||| 0|eng d
020	6	4	_a9788847004344 _9978-88-470-0434-4
024	8	7	_a10.1007/88-470-0434-9 _2doi
050	8	4	_aRD544
072	8	7	_aMNG _2bicssc
072	8	7	_aMED085060 _2bisacsh
082			_a617.555 _223
100	8	1	_aDelaini, Gian Gaetano. _eeditor. _9222120
245	9	7	_aInflammatory Bowel Disease and Familial Adenomatous Polyposis _h[electronic resource] : _bClinical Management and Patients Quality of Life / _cedited by Gian Gaetano Delaini.
001			000076580
300	6	4	_aXX, 482 p. _bonline resource.
505	8	0	_aGeneral Approach -- MRI in Inflammatory Small-Bowel Diseases -- Inflammatory Bowel Disease -- IBD: Epidemiology and Risk Factors -- Inflammatory Bowel Disease: the Pathologists Approach to the Clinical Problem -- Dysplasia in Inflammatory Bowel Disease: from Genetics to Treatment -- IBD: Cancer Risk and Surveillance -- Colonic and Anorectal Motility in Inflammatory Bowel Disease -- Extraintestinal Manifestations of Inflammatory Bowel Disease -- Perianal Crohns Disease: Assessment with Endoanal Ultrasonography -- Endoscopy in Crohns Disease -- Role of Endoscopy in Ulcerative Colitis -- Nutrition and Malnutrition in Inflammatory Bowel Disease -- Probiotics in Inflammatory Bowel Diseases -- Quality of Life in Patients Undergoing Colorectal Surgery -- IBD and Pregnancy -- Urinary and Sexual Involvement in IBD -- Biological Approach in the Treatment of Crohns Disease -- Medical Therapy of Fistulizing Crohns Disease -- Surgical Options in Small-Bowel Disease -- Crohns Disease of the Colon -- Laparoscopy for the Treatment of Crohns Disease -- Postoperative Prevention of Relapse in Crohns Disease -- Surgical Treatment of Perineal Crohns Disease -- Medical Treatment of Ulcerative Colitis -- Indications for Surgical Treatment of Ulcerative Colitis -- Surgical Management of Acute Ulcerative Colitis -- The Cancer Risk in Longstanding Ulcerative Colitis: Surveillance Colonoscopy and Prophylactic Surgery -- Salvage Surgery After Restorative Proctocolectomy -- Management of the Difficult Ileal Pouch-Anal Anastomosis and Temporary Ileostomy -- Open Questions in Restorative Proctocolectomy -- Follow-Up of Restorative Proctocolectomy: Clinical Experience of a Specialised Pouch Clinic -- Management of Pouchitis -- Bowel Transplantation for Inflammatory Bowel Disease -- Liver Transplantation for Primary Sclerosing Cholangitis and Inflammatory Bowel Disease -- Familial Adenomatous Polyposis -- Emergent Issues and Future Trends in Familial Adenomatous Polyposis -- Genetic Mutations in FAP and Conventional or Laparoscopic Surgical Approach -- Clinical Significance of Extra-Colonic Manifestations of Familial Adenomatous Polyposis -- Desmoid Tumours in Familial Adenomatous Polyposis -- The Endoscopic Procedures in Familial Adenomatous Polyposis (FAP): a Critical Review -- FAP History Through a Patients Story -- Ileo-Rectal Anastomosis vs. Ileo-Anal Pouch as the Surgical Treatment for Familial Adenomatous Polyposis -- Surgery and Surveillance in Colon Polyposis Syndrome -- Special Topics -- Psyche and Colitis: What the Surgeon Should Know -- Interdisciplinary Management of Inflammatory Bowel Diseases -- Interdisciplinary Management of Familial Adenomatous Polyposis -- Ileoanal Pouches and Indeterminate Colitis -- Quality of Life in the Pouch Patient -- The Place of Proctocolectomy with Ileostomy in the Era of Restorative Proctocolectomy -- Surgical Management of IBD Emergencies: the Approach in a Peripheral Hospital -- Management of the Unhealed Perineal Wound -- Rehabilitation in Patients with Inflammatory Bowel Disease and Familial Adenomatous Polyposis.
520	6	4	_aInflammatory bowel disease (IBD) and familial adenomatous polyposis (FAP) are complex diseases, which are subject to numerous medical researches. Despite increased knowledge on the pathophysiological process, many aspects remain rather unclear, especially concerning IBD. The genetic basis of FAP is well known, but there is still debate about IBD, which seems more likely to be a multifactorial disease, where the illness is due to interactions between environmental and genetic factors. In the near future, the aim will be to prevent these disorders and their sequelae through early detection and early intervention (for example genetic therapy). Unfortunately, we are still dealing with young patients with a lifelong disease course, leading to early morbidity (and in some cases mortality) and extended needs for medical treatment, with a consequent decrease in quality of life. IBD and FAP represent a challenge for a multidisciplinary medical approach where different personnel play major roles in different stages of the patients treatment. It is in this light that basic scientists, geneticists, pathologists, radiologists, gastroenterologists, surgeons, psychologists and WOC/ET nurses have to work together in order to improve the outlook of these patients and their families.
650	8	0	_aMedicine. _94382
650	8	0	_aGastroenterology. _99018
650	8	0	_aPathology. _99495
650	8	0	_aSurgery. _99021
650	8	0	_aColon (Anatomy) _xSurgery. _918421
650	8	0	_aQuality of Life. _911607
650	8	0	_aQuality of Life _xResearch. _911608
650			_aMedicine & Public Health. _9222121
650			_aColorectal Surgery. _918423
650			_aGastroenterology. _99018
650			_aSurgery. _99021
650			_aPathology. _99495
650			_aQuality of Life Research. _911612
710	8	2	_aSpringerLink (Online service) _9222122
773	8	0	_tSpringer eBooks
776			_iPrinted edition: _z9788847004337
856			_uhttp://dx.doi.org/10.1007/88-470-0434-9 _zde clik aquí para ver el libro electrónico
264	8	1	_aMilano : _bSpringer Milan, _c2006.
336	6	4	_atext _btxt _2rdacontent
337	6	4	_acomputer _bc _2rdamedia
338	6	4	_aonline resource _bcr _2rdacarrier
347	6	4	_atext file _bPDF _2rda
912	6	4	_aZDB-2-SME
999			_c76310 _d76310
942			_c05